Drugs / AZD1704
last change Sep 2008 re-read 3 minutes ago

AZD1704

Investigated by
AstraZeneca

Trials 2

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00736788 Aug → Sep 2008 — AstraZeneca Terminated No outcome recorded
Phase 1 NCT00692042 Mar → Jun 2008 — AstraZeneca Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as AZD1704 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00692042 ↗
1

NCT00736788 ↗

Route Oral “One dose, by mouth” NCT00692042 ↗